Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2.
about
Design of group IIA secreted/synovial phospholipase A(2) inhibitors: an oxadiazolone derivative suppresses chondrocyte prostaglandin E(2) secretionPhospholipase A2: its usefulness in laboratory diagnostics.Glucocorticoid deficiency increases phospholipase A2 activity in ratsCytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction.Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.Cytokine regulation of mast cell protease phenotype and arachidonic acid metabolism.Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2.Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role.Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan.Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate.Association of type II secretory phospholipase A2 and surfactant protein D with the pulmonary oxygenation potential in patients with septic shock during polymyxin-B immobilized fiber-direct hemoperfusion.
P2860
Q28474126-EE787F91-80B5-43EB-8E6B-29BAB67882D6Q33702391-3057E903-AFFE-4F25-B86E-A2D15AA1ACB3Q33905743-A9557FDD-3C08-497E-AAED-2369359DE31DQ33908899-0C6E1120-7530-48C1-9BFD-23A7B5B13D19Q36069717-69DC891D-6B10-43D7-B42A-E0CB1395CE7BQ36330372-236CC058-7A9B-4BE2-B0FE-0D551F3FDC41Q37365835-4AB8864D-FA3F-4C30-B216-940A6E5B6F32Q40572582-74350485-78D5-4859-AABE-81AD6DAE4BBCQ41094611-49289E74-8304-40F2-8CC9-8459FD691184Q41369339-5FB0D1CD-A6D9-404D-A2DB-37179E2B7D95Q41508409-A047ACB0-2983-4D9C-B776-05C73B987381Q42685759-C538D9D8-7589-44B3-A510-F16EBD178756Q51456273-60F87C77-5181-4CFE-AB1F-BF824ACD9C1E
P2860
Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@en
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@nl
type
label
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@en
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@nl
prefLabel
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@en
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@nl
P2093
P2860
P1433
P1476
Exacerbation of rat adjuvant a ...... kDa group II phospholipase A2.
@en
P2093
P2860
P304
P356
10.1016/0014-5793(90)80986-S
P407
P577
1990-07-01T00:00:00Z